• Home>
  • Stocks>
  • Aarey Drugs & Pharmaceuticals Ltd Share Price
Aarey Drugs & Pharmaceuticals Ltd share price logo

Aarey Drugs & Pharmaceuticals Ltd Share Price

NSE: AAREYDRUGS

BSE: 524412

Small Cap

Healthcare Sector

96.25

+1.28

(+1.35%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Aarey Drugs & Pharmaceuticals Ltd Stock Performance

as on November 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹94.97
    ₹96.86
    downward going graph

    1.33%

    Downside

    0.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹31.35
    ₹96.86
    downward going graph

    67.43%

    Downside

    0.63%

    Upside

    downward going graph

Aarey Drugs & Pharmaceuticals Ltd share price movements today

Previous Close
₹94.97
Open
₹96.25
Volume
1.22L
Upper Circuit
₹96.86
Lower Circuit
₹93.07
Day's Low - High
₹94.97 - ₹96.86
52 Week Low - High
₹31.35 - ₹96.86

Aarey Drugs & Pharmaceuticals Ltd Historical Returns

1 Month Return
+ 15.51 %
3 Month Return
+ 38.02 %
1 Year Return
+ 50.46 %
3 Year Return
+ 152.92 %
5 Year Return
+ 119.08 %

Aarey Drugs & Pharmaceuticals Ltd Fundamentals

as on November 3, 2025 at 4:01 pm IST

Market Cap

₹269.28 Cr

Return on Equity (ROE)

2.96

PE Ratio (TTM)

0

Return on capital employed (ROCE)

6.38

Beta (LTM)

0.95

P/B Ratio

0.72

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

10.48

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Aarey Drugs & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarey Drugs & Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA269.2823.82%0.004473
NA35.34-6.86%0.823168
NA513.82159.58%0.95-14125
NA192.6729.43%0.5019112
NA1,363.91-1.51%0.7428311

Aarey Drugs & Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Search interest for Aarey Drugs & Pharmaceuticals Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Aarey Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
62.47
162.88
50.96
57.83
76.48
210.35
126.91
105.14
133.79
108.1
102.21
Other Income
0.48
0.84
0.7
0.84
0.29
5.14
1.58
0.02
0.68
7.54
1.55
Total Income
62.95
163.72
51.65
58.67
76.77
215.49
128.49
105.16
134.47
115.64
103.76
Expenses
60.94
160.36
49.62
55.98
73.77
211.79
125.73
101.42
131.59
112.3
100.51
Operating Profit
1.53
2.52
1.34
1.85
2.71
-1.44
1.18
3.72
2.2
-4.2
1.7
Operating Profit Margin %
2.45%
1.55%
2.63%
3.2%
3.54%
-0.68%
0.93%
3.54%
1.64%
-3.89%
1.66%
Profit Before Interest, Tax and Depreciation
2.01
3.36
2.04
2.68
3
3.7
2.75
3.74
2.88
3.33
3.25
Interest
0.71
0.2
0.42
0.41
0.47
0.4
0.96
0.49
0.58
1.3
1.04
Depreciation
0.55
1.02
0.89
1.27
1.06
1.15
0.47
1.51
0.9
0.41
0.49
Profit Before Tax
0.75
2.14
0.73
1
1.47
2.15
1.32
1.74
1.4
1.62
1.72
Tax Paid
-0.25
1.78
-
-0.22
0.44
-0.01
0.09
0.15
0.68
1.16
0.36
Profit After Tax
1
0.36
0.72
1.23
1.02
2.15
1.24
1.6
0.72
0.47
1.37
Total Net profit including share of profit / Loss from associate company
1
0.36
0.72
1.23
1.02
2.15
1.24
1.6
0.72
0.47
1.37
EPS
0.39
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
Actual EPS
0.39
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
Adjusted EPS
0.39
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
Diluted EPS
0.39
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48

Aarey Drugs & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
395.97
349.35
354.74
300.09
348.42
492.68
418.96
395.62
473.94
Other Income
3.34
3.18
4.34
6.69
7.01
2.75
2.73
6.96
9.81
Total Income
399.3
352.53
359.08
306.78
355.43
495.43
421.69
402.58
483.76
Expenses
386.44
341.75
346.86
296.89
343.78
481.41
411.23
391.17
471.04
Operating Profit
9.53
7.6
7.88
3.2
4.64
11.27
7.73
4.45
2.9
Operating Profit Margin %
2.41%
2.18%
2.22%
1.07%
1.33%
2.29%
1.85%
1.12%
0.61%
Profit Before Interest, Tax and Depreciation
12.87
10.78
12.22
9.89
11.65
14.02
10.46
11.42
12.71
Interest
4.25
1.88
2.23
1.76
2.43
2
1.57
1.7
4.66
Depreciation
0.64
0.71
1.01
0.89
0.92
1.99
2.87
4.38
1.94
Profit Before Tax
7.98
8.19
8.98
7.24
8.3
10.03
6.02
5.34
6.11
Tax Paid
2.51
2.01
2.44
1.45
1.78
3.48
2.24
0.66
2.08
Profit After Tax
5.47
6.18
6.54
5.79
6.51
6.54
3.78
4.68
4.02
Total Net profit including share of profit / Loss from associate company
5.47
6.18
6.54
5.79
6.51
6.54
3.78
4.68
4.02
EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
Actual EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
Adjusted EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
Diluted EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.84

Aarey Drugs & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
5.66
0.62
-20.35
0.69
2.86
5.48
0.5
-1.28
-2.99
10.3
Cash Flow from Investing Activities
-2.58
-4.97
-0.6
-1.23
-0.92
-2.88
-3.21
0.45
-1.7
-5.94
Cash Flow from Financing Activities
-1.63
3.74
23.3
-2.48
-1.81
-2.45
2.25
1.35
5.57
-4.48
Net Cash Flow
1.45
-0.58
2.35
-3.02
0.13
0.15
-0.46
0.51
0.89
-0.12

Aarey Drugs & Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Aarey Drugs & Pharmaceuticals Ltd.

  • Aarey Drugs & Pharmaceuticals Ltd Earnings Results

    Aarey Drugs & Pharmaceuticals Ltd’s net profit jumped 10.48% since last year same period to ₹1.37Cr in the Q1 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated 191.49% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Aarey Drugs & Pharmaceuticals Ltd Dividends November,2018

    In the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 30 Nov 2018 - translating a dividend yield of 0.11%.

    Read More about Dividends

Insights on Aarey Drugs & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.23% to 54.07% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AAREYDRUGS stock has moved up by 6.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AAREYDRUGS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AAREYDRUGS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.80% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.97% to 1.13% in Sep 2025 quarter

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs Pharmaceuticals Ltd is one of the India's leading manufacturers and suppliers of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, APIs, drugs, food colours and flavours. The company is equipped with a manufacturing unit located in Thane and has its corporate office in Mumbai. It was established in 1990 and is governed by central and state legislations that regulate the business. Their products meet the IP/ BP/ CP/ USP standards and are sourced from authentic vendors to guarantee quality and effectiveness. The company floated a public issue in 1993 of 27.5 lakh equity shares of Rs. 10 each and was listed on 3 stock exchanges. In 2009, the plant was upgraded to international standards. They also plan to manufacture new products and expand the existing production capacity of Metronidazole MTZ from 420 MT to 780 MT and Metronidazole Benzoate MBO from 120 MT to 240 MT. Aarey Drugs and Pharmaceuticals Ltd is a trusted manufacturer of pharmaceutical products and has been providing quality products since its establishment.

Revenue: ₹102.21Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1.37Cr as on June 2025 (Q1 FY26)
Listing date: 06 Aug, 2021
Chairperson Name: Mihir R Ghatalia
OrganisationAarey Drugs & Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOMihir R Ghatalia
E-voting on sharesClick here to vote

FAQs

What is Aarey Drugs & Pharmaceuticals Ltd share price today?

Aarey Drugs & Pharmaceuticals Ltd share price today stands at ₹96.25 as on at the close of the market. Aarey Drugs & Pharmaceuticals Ltd share today touched a day high of ₹96.86 and a low of ₹94.97.

What is the 52 week high and 52 week low range for Aarey Drugs & Pharmaceuticals Ltd share?

Aarey Drugs & Pharmaceuticals Ltd touched a 52 week high of ₹96.86 and a 52 week low of ₹31.35. Aarey Drugs & Pharmaceuticals Ltd share price today i.e. is closed at ₹96.25, which is -0.63% down from its 52 week high and 207.02% up from its 52 week low.

What is Aarey Drugs & Pharmaceuticals Ltd's market capitalisation today?

Aarey Drugs & Pharmaceuticals Ltd market capitalisation is ₹269.28 Cr as on .

How to buy Aarey Drugs & Pharmaceuticals Ltd shares?

To buy Aarey Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AAREYDRUGS or Aarey Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarey Drugs & Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarey Drugs & Pharmaceuticals Ltd trading volume today?

Aarey Drugs & Pharmaceuticals Ltd trading volume is 1.22L as on . This means that 1.22L shares of Aarey Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.